Publications of Sven Göbel
All genres
Talk (13)
21.
Talk
Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16th PEACe Conference, Sitges (Spain) (2023)
22.
Talk
Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)
23.
Talk
Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)
24.
Talk
Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)
25.
Talk
Intensifiying OSB processes for high titer virus production. 5th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)
26.
Talk
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)
27.
Talk
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)
28.
Talk
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)
Poster (8)
29.
Poster
Advanced sensors for automation of online and inline assays in biomanufacturing using imaging and AI. NIIMBL National Meeting, Washington D.C. (USA) / virtually (2025)
30.
Poster
Multifactorial highthroughput process screening for a yellow-fever virus vectored Zika vaccine candidate. Vaccine Technology IX, Los Cabos (Mexico) (2024)
31.
Poster
Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. 28th ESACT Meeting, Edingburgh (Scotland) (2024)
32.
Poster
HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic Vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)
33.
Poster
Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion Culture. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)
34.
Poster
Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)
35.
Poster
Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)
36.
Poster
Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)
Thesis - PhD (1)
37.
Thesis - PhD
Production of a fusogenic oncolytic virus: In-depth process development and process intensification. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2024)
Preprint (1)
38.
Preprint
A high cell density perfusion process for MVA virus production: process integration with inline DNA digestion and cost analysis. Authorea Preprints (2021)